Hormesis: How Small Doses of Stress Make Cells Stronger

Key Takeaways
- Hormesis is a dose response. The same agent helps at a low dose and harms at a high one.
- The benefit has a ceiling. Across thousands of catalogued dose responses, the low-dose gain tops out around 30% to 60% above baseline.
- The word comes from toxicology in 1943. It reached nutrition and exercise science much later.
- Mitohormesis is the version driven by mitochondria. Xenohormesis is the version driven by plant chemistry, and it is still only a hypothesis.
- Nobody can measure where your own threshold sits. That is the framework's real limit.
What Is Hormesis?
Hormesis is a two-phase response to dose. The same agent stimulates at low exposure and holds back at high exposure. The word first appeared in print in 1943. Two plant pathologists reported that a hot-water extract of western red-cedar heartwood sped the growth of certain wood-decaying fungi when heavily diluted, and killed them when concentrated.
They proposed the noun and the adjective in the same sentence. The root is the ancient Greek verb hormáein, meaning to excite or to set in motion.
Two definitions are now in use, and they aren't quite the same. Toxicologists use hormesis for the shape of a dose-response curve, measured across a population of cells or organisms. Biologists and doctors use it more loosely, for an adaptive response of cells and organisms to a moderate, usually intermittent stress.
The second definition sits behind sauna routines and fasting windows. It's the looser of the two, because it describes a mechanism instead of a measurement. Keeping the distinction in view makes it easier to see which claims about hormesis rest on data and which rest on analogy.
What Does a Hormetic Dose Response Look Like?
It looks like a curve that rises modestly above baseline, peaks, then falls through baseline into harm. Which way it bends depends on what's being measured. A growth or longevity endpoint produces an inverted U, while a disease-incidence endpoint produces a U or a J. Same phenomenon, mirrored on the page, because low disease incidence is a good outcome and low growth is not.
The upside on that curve is small. Reviews of the catalogued literature put the maximum stimulatory response at roughly 30% to 60% above the unstressed control, and only rarely more than twice the control response. The useful band is narrow too. It sits roughly 10-fold to 20-fold below the dose where the same agent turns toxic.
The word “typical” is carrying weight there. Those figures come from a curated database of cell and animal toxicology. They describe a tendency across many agents. They aren't a rule that transfers to a person deciding how long to sit in a sauna.
![]() |
The science: Hormesis shows up often enough in toxicology to be catalogued, but it is far from universal. How often it appears depends on how you screen for it. The evidence: A screen of 20,285 papers found 668 dose responses that met the entry rules set in advance. Of those 668, 245 met the test for hormesis. That is 37% of a pre-screened set, not 37% of the literature (Calabrese & Baldwin, 2001, Toxicological Sciences). |
Where Did the Idea of Hormesis Come From?

Toxicology, by way of a 19th-century argument about homeopathy that went badly for everyone involved. Hugo Schulz was a German pharmacologist at Greifswald in the 1880s. He tested about a dozen chemical disinfectants on yeast. Below a certain strength, the yeast gave off more carbon dioxide than untreated controls.
Schulz and his Greifswald colleague Rudolph Arndt turned that into what they named a biological law: small doses stimulate, moderate doses inhibit, large doses kill. Then Schulz claimed he had found the explanatory principle behind homeopathy. Mainstream medicine reacted about as you would expect.
Edward Calabrese is the toxicologist who has done the most to revive the concept. He argues that the homeopathy link is why the two-phase dose response was pushed to the margins of 20th-century toxicology. Other historians of science contest that account. Calabrese has also disclosed that parts of his hormesis program were funded by the US Air Force and the ExxonMobil Foundation. Both have a stake in how regulators set exposure limits.
Hormesis has a second life in toxicology. There it feeds a contested debate about low-dose radiation, one that carries political freight of its own. Over the last two decades it has also moved into nutrition, exercise science, and aging research. That is where it reaches your routine.
What Counts as a Hormetic Stressor?
Five kinds of hormetic stressors come up again and again: exercise, heat, cold, eating less, and plant compounds. They get grouped together because each one sets off an adaptive stress response instead of simply causing damage. How well each is backed by evidence varies a great deal.
| Stressor | Adaptive machinery usually credited | How settled the human evidence is |
|---|---|---|
| Physical exercise | Mitochondrial biogenesis, antioxidant enzyme upregulation, Nrf2 signaling | Strongest of the five. Both ends of the curve are described in the exercise literature. |
| Heat | Heat shock factor 1 and the heat shock proteins | Mixed. Circulating HSP70 rises in small studies; skeletal muscle HSP content has not. |
| Cold | Not well characterized within the hormesis literature | Weakest of the five. Rapid cold hardening is documented in animals; human dosing is unstudied. |
| Dietary energy restriction | AMPK, autophagy, a modest rise in circulating glucocorticoids | Strong in rodents. Human lifespan data does not exist. |
| Dietary phytochemicals | Keap1 and Nrf2 signaling, sirtuins | Mechanism well supported in cells and animals. Human confirmation is limited and mostly low quality. |
Exercise is the best-studied member of the group and is covered separately elsewhere on this site, including a dose-response figure drawn for training. If that's what brought you here, start with how exercise raises oxidative stress in the short term and lowers it over time.
Dietary energy restriction has the cleanest hormetic logic of the five. The level of restriction that extends lifespan in rodents also improves their ability to cope with intense stressors and slightly raises their daily peak of corticosterone, a stress hormone. That's what a low-intensity stressor is supposed to do. It's also rodent work, and Edward Masoro, who made the case, treated hormesis as one mechanism among several.
Phytochemicals belong on the list for a reason that surprises most readers. The compounds evolved as pest deterrents, and at the subtoxic amounts humans eat they induce mild cellular stress responses. The best-worked example on this site is the enzyme step that has to happen before broccoli compounds become sulforaphane.
Cold is the outlier. Popular writing groups it with the other four constantly, but it's largely absent from the formal hormesis taxonomies. The closest solid work is on rapid cold hardening in insects and other animals, not in people. The concept fits; the human dosing evidence hasn't been collected.
Where the Idea Was First Tested
One older result sits underneath all five. In 1986, brief cycles of coronary blockage in dogs, delivered before a sustained 40-minute blockage, limited the resulting heart damage to about a quarter of the control size. The same paper found no benefit when the blockage ran three hours. Preconditioning delayed cell death without stopping it, which is a useful ceiling to carry into everything that follows.
Heat Shock Proteins: The Machinery Behind Heat Adaptation
Heat shock proteins are the clearest worked example of hormetic machinery. They are also why heat gets discussed alongside exercise and fasting. They work as chaperones: proteins that help other proteins fold correctly, and that clean up the ones that come apart under stress.
How the Heat Shock Response Was Discovered
By accident, in 1962. Ferruccio Ritossa found a new pattern of chromosomal puffing in fruit fly salivary glands after a temperature shock, which is a visible sign of genes switching on. Someone in the lab had changed the incubator temperature, and Ritossa could never establish who.
Two details of that paper usually get lost. What Ritossa found was the transcriptional response, meaning the genes switching on. The proteins themselves were identified in 1974 as the products of those puffs, 12 years later. The 1962 title also names a chemical alongside heat, because a drug that uncouples mitochondria produced the same puffing pattern. The response tracks cellular stress in general.
What the Human Evidence Shows

Less than the popular version claims. The mechanism is well described. Heat shock factor 1 assembles, moves into the nucleus, binds the relevant gene promoters, and drives production of the chaperones. In humans the measurements are thinner, and they split by compartment.
In blood, the response shows up. Young healthy adults sat in a 73 °C chamber for 30 minutes and their circulating HSP72 rose by an average of 48.7%. The variation between people was larger than the effect itself, and blood was drawn from only 13 of the 25 participants.
In skeletal muscle it doesn't. Raising muscle temperature by 3.6 °C in physically active men produced no significant increase in four different heat shock proteins, measured at 48 hours and again at seven days.
![]() |
The science: Heat shock proteins can extend lifespan when the genes that make them are turned up directly. Whether heat does anything comparable in a person is an open question. The evidence: In the roundworm C. elegans, turning heat shock factor down shortens life, and turning it up lengthens it (Hsu, Murphy, & Kenyon, 2003, Science). No human study has shown that raising heat shock proteins extends human life. |
What Is Mitohormesis?
Mitohormesis is hormesis with the mitochondria as the source of the signal. Mitochondria are the structures that make energy inside a cell, and they release reactive oxygen species as a byproduct. The claim is that a modest rise in those byproducts acts as a message rather than as damage, and that the message leaves the cell better defended afterwards.
The term was coined in 2006 by Patrick Tapia, in a hypothesis paper in Medical Hypotheses. That journal published speculative ideas under editorial review at the time, not conventional peer review. Michael Ristow's group supplied the first experiment a year later and did the most to establish the concept, and Ristow's own reviews credit Tapia for the word.
The 2007 experiment is worth knowing in detail. Restricting glucose in the roundworm C. elegans extended lifespan by driving up mitochondrial respiration and oxidative stress, and treating the worms with antioxidants abolished the extension. The worm version of AMPK, a cellular energy sensor, was required for the effect. The sirtuin was not.
Two caveats bear on that result. The glucose restriction was produced with a drug, 2-deoxy-D-glucose, which blocks the cell's main sugar-burning pathway. Fed chronically, that same compound damages heart tissue and raises mortality in rats.
The wider claim that antioxidants blunt adaptation is not universal either. One rat study used very large vitamin C and E doses. It confirmed the antioxidant effect on oxidative markers, yet the rats still adapted to training normally. Ristow has said so in print. Whether high-dose antioxidant supplements blunt training in people is covered in the piece on why more antioxidant is not automatically better after exercise.
What Is Xenohormesis?
Xenohormesis is the proposal that animals and fungi read the chemistry of stressed plants as an early warning. A plant under drought, cold, or attack makes different compounds than a comfortable one. The idea is that organisms evolved to respond to stress-signalling molecules made by other species. They then use those signals to get ready for hard conditions while conditions are still good.

It's an elegant idea with a difficult evidence base. The flagship demonstration came in 2003, when a team reported that resveratrol activated the enzyme SIRT1 and extended yeast lifespan by 70%. That result made resveratrol famous.
It did not hold up in the form it was published. The assay used a test peptide carrying a fluorescent dye, and three independent groups showed the apparent activation depended on that dye.
Removing the dye removed the effect, and the same group could not reproduce the yeast lifespan extension. A second found the activation completely dependent on an attached dye whatever the peptide sequence. A third, working with untagged peptides and the full-length protein, reported that resveratrol and three synthetic compounds were not direct activators of SIRT1 at all. The molecules were binding the dye.

Six of the 12 authors on the 2003 paper were affiliated with the company that made the assay kit in question, with disclosed equity and a joint patent filing. The 2010 rebuttal came entirely from a Pfizer research team, at a point when the resveratrol program belonged to a competitor. Neither fact settles the science.
Its own authors are candid about where that leaves the hypothesis. They concluded that xenohormesis likely occurs at some level, but that whether it can account for the effects of resveratrol and other polyphenols remains to be seen. They also acknowledged a dose problem: for many polyphenols the research dose exceeds what diet can supply. Twenty years on, xenohormesis remains an unproven framework. The advice to eat a wide range of plants rich in polyphenols rests on firmer ground than the evolutionary story offered to explain it.
Where the Hormesis Argument Breaks Down
In two places, and both of them matter for anyone using hormesis to make decisions.
The Dose Threshold Cannot Be Measured for an Individual
The curve in Figure 1 has a threshold on it. In a laboratory that point is estimated across a population of cells or organisms at controlled doses. In a person it isn't observable. No test reports where your stimulatory zone ends and your inhibitory zone begins, for heat, cold, training load, or anything else.
The overtraining literature makes this concrete. A joint statement from the European College of Sport Science and the American College of Sports Medicine reviewed every candidate marker. It found that none of them meet all the criteria required for general acceptance. Overtraining syndrome is the clearest case of a hormetic stressor going past its threshold, and it still has no proven marker.
Why “More Is Better” Misreads the Curve
Because the curve describes a ceiling as much as a benefit. Reviewers of the hormesis database argue that the consistently modest stimulatory range defines the limits of biological plasticity. Past the peak, extra stress buys harm in place of more benefit.
Researchers who work on aging describe the useful stress as mild and periodic rather than severe or chronic. The exercise literature makes the same point as two ends of one curve. Sitting still is one end, and too much exercise and overtraining sit at the other.
Where the far end sits in humans is unsettled. A pooled analysis of 661,137 adults found benefit levelling off at three to five times the recommended activity minimum, and no evidence of harm at 10 times the minimum. The much-cited Danish finding of a U-shaped mortality curve for jogging rests on 40 strenuous joggers and two deaths. Its confidence interval runs from 0.48 to 8.14, which spans substantial benefit and substantial harm, so it settles nothing.
Dose Sets the Direction. Recovery Sets the Ceiling.

Hormesis is a real, well-documented pattern in dose-response biology. It is also a smaller effect than the enthusiasm around it implies. Most of the work is in cells and animals, and the threshold cannot be pinned down for any one person.
What survives all of that is a working principle. Stressors the body adapted to over evolutionary time produce adaptation when they're moderate and intermittent, and damage when they're severe or unrelenting. The variable that decides which one you get is recovery. The same sauna session, the same training week, and the same fasting window land on either side of the line depending on what follows them.
That reframes the practical question. The evidence can't tell you how cold, how hot, or how long. It can tell you that the exposure should be repeated at a level you recover from completely. That's the version of hormesis that supports healthy aging over years, and it's the version that survives every caveat above.
Dose decides whether a stressor helps or harms. Recovery decides which one you get.
What Hormesis Implies for Antioxidant Supplements
The practical question is whether antioxidants taken around a workout or a sauna session cancel the point of doing it. The tension is real and worth understanding, and it's conceptual before it's practical.
If part of the benefit of exercise, heat, and plant compounds comes from a brief stress signal, anything that mutes that signal could in principle mute the adaptation. That's the concern behind the advice to skip high-dose vitamin C and E immediately after training.
The mechanism turns out to be more interesting than that. One review argues that direct scavenging of free radicals is ineffective as a defense mechanism in living tissue. On that account, dietary antioxidants work mostly by gently oxidizing a sensor protein, which switches on the cell's own defense genes. The authors call this para-hormesis. On that reading, a compound many people file under antioxidant is doing its work as a mild stressor.
How well that holds up in people is another matter. A systematic review looked at 18 human trials. Roughly half reported a rise in Nrf2 activity, but the reviewers rated many of those trials poor quality or at unclear-to-high risk of bias. Their verdict was that evidence that phytochemicals activate this pathway in humans is currently limited.
Those two jobs are why the ResilienZ-12™ formula keeps them separate. The Signal pillar covers ingredients chosen to activate the cell's own defense pathways. The Shield pillar covers direct antioxidant protection across water-based and fat-based cellular environments. The mechanism behind that split is worked through in the pieces on what happens to cellular defenses after midlife and the Four-Pillar Framework for cellular resilience. Every dose is printed on the ResilienZ-12™ ingredients page.
Studies cited above describe ingredients, mechanisms, and dietary patterns, not the ResilienZ-12™ formula. Ingredient and dose selection in ResilienZ-12™ is informed by this research, not equivalent to it.
Frequently Asked Questions
What is hormesis in simple terms?
In simple terms, hormesis is when a small dose of something harmful makes a living thing stronger, while a large dose of the same thing does harm. Exercise is the everyday example. A hard workout stresses muscle, and the rest that follows leaves it better able to handle the next one.
What is hormetic stress?
Hormetic stress is a stressor given at a dose low enough to trigger adaptation instead of injury. The common hormetic stressors are exercise, heat, cold, eating less, and plant compounds. What makes a stress hormetic is the amount you get and the rest you allow after it.
What is mitohormesis?
Mitohormesis is the version of hormesis in which mitochondria send the signal. A small rise in the reactive byproducts of working mitochondria acts as a cue for the cell to raise its defenses. Most of the evidence comes from worm studies, and the drug used in the main one harms rats.
What is xenohormesis?
Xenohormesis is the idea that animals sense stress compounds made by plants and read them as an early warning. Its best-known example was resveratrol switching on the enzyme SIRT1. That result turned out to be a flaw in the lab test. Xenohormesis is still only a hypothesis.
How is hormesis measured?
Hormesis is measured by testing a range of doses and plotting the response to each one, then checking whether low doses beat the untreated control. That works in a lab, where the doses are set. There is no such test for one person choosing a sauna length or a training load.
How much stress is the right amount for hormesis?
The right amount of stress for hormesis cannot be given as a number, because the threshold has never been measured in one person. The research supports stress that is moderate, repeated, and followed by real recovery. It gives no support to raising the dose, and the benefit is small even at the peak.
FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This article draws on 41 peer-reviewed sources, 40 of them linked in the references below.
References
Anckar, J., & Sistonen, L. (2011). Regulation of HSF1 function in the heat stress response: Implications in aging and disease. Annual Review of Biochemistry, 80, 1089–1115.
Arem, H., Moore, S. C., Patel, A., Hartge, P., Berrington de Gonzalez, A., Visvanathan, K., ... Matthews, C. E. (2015). Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship. JAMA Internal Medicine, 175(6), 959–967.
Baur, J. A., & Sinclair, D. A. (2008). What is xenohormesis? American Journal of Pharmacology and Toxicology, 3(1), 152–159.
Berry, R., III, & López-Martínez, G. (2020). A dose of experimental hormesis: When mild stress protects and improves animal performance. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 242, 110658.
Borra, M. T., Smith, B. C., & Denu, J. M. (2005). Mechanism of human SIRT1 activation by resveratrol. Journal of Biological Chemistry, 280(17), 17187–17195.
Calabrese, E. J. (2004). Hormesis: A revolution in toxicology, risk assessment and medicine. EMBO Reports, 5(S1), S37–S40.
Calabrese, E. J. (2016). The emergence of the dose-response concept in biology and medicine. International Journal of Molecular Sciences, 17(12), 2034.
Calabrese, E. J., & Baldwin, L. A. (2000). The marginalization of hormesis. Human & Experimental Toxicology, 19(1), 32–40.
Calabrese, E. J., & Baldwin, L. A. (2001). Hormesis: U-shaped dose responses and their centrality in toxicology. Trends in Pharmacological Sciences, 22(6), 285–291.
Calabrese, E. J., & Baldwin, L. A. (2001). The frequency of U-shaped dose responses in the toxicological literature. Toxicological Sciences, 62(2), 330–338.
Calabrese, E. J., & Baldwin, L. A. (2002). Defining hormesis. Human & Experimental Toxicology, 21(2), 91–97.
Calabrese, E. J., & Blain, R. B. (2011). The hormesis database: The occurrence of hormetic dose responses in the toxicological literature. Regulatory Toxicology and Pharmacology, 61(1), 73–81.
Calabrese, E. J., & Mattson, M. P. (2017). How does hormesis impact biology, toxicology, and medicine? npj Aging and Mechanisms of Disease, 3, 13.
Clifford, T., Acton, J. P., Cocksedge, S. P., Davies, K. A. B., & Bailey, S. J. (2021). The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: A systematic review of human intervention trials. Molecular Biology Reports, 48(2), 1745–1761.
De Maio, A., Santoro, M. G., Tanguay, R. M., & Hightower, L. E. (2012). Ferruccio Ritossa’s scientific legacy 50 years after his discovery of the heat shock response: A new view of biology, a new society, and a new journal. Cell Stress and Chaperones, 17(2), 139–143.
Forman, H. J., Davies, K. J. A., & Ursini, F. (2014). How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radical Biology and Medicine, 66, 24–35.
Higashida, K., Kim, S. H., Higuchi, M., Holloszy, J. O., & Han, D. H. (2011). Normal adaptations to exercise despite protection against oxidative stress. American Journal of Physiology-Endocrinology and Metabolism, 301(5), E779–E784.
Howitz, K. T., & Sinclair, D. A. (2008). Xenohormesis: Sensing the chemical cues of other species. Cell, 133(3), 387–391.
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., ... Sinclair, D. A. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425(6954), 191–196.
Hsu, A.-L., Murphy, C. T., & Kenyon, C. (2003). Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science, 300(5622), 1142–1145.
Iguchi, M., Littmann, A. E., Chang, S.-H., Wester, L. A., Knipper, J. S., & Shields, R. K. (2012). Heat stress and cardiovascular, hormonal, and heat shock proteins in humans. Journal of Athletic Training, 47(2), 184–190.
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., ... Kennedy, B. K. (2005). Substrate-specific activation of sirtuins by resveratrol. Journal of Biological Chemistry, 280(17), 17038–17045.
Lamming, D. W., Wood, J. G., & Sinclair, D. A. (2004). Small molecules that regulate lifespan: Evidence for xenohormesis. Molecular Microbiology, 53(4), 1003–1009.
Mao, L., & Franke, J. (2013). Hormesis in aging and neurodegeneration: A prodigy awaiting dissection. International Journal of Molecular Sciences, 14(7), 13109–13128.
Masoro, E. J. (2007). Role of hormesis in life extension by caloric restriction. Dose-Response, 5(2), 163–173.
Mattson, M. P. (2008). Hormesis defined. Ageing Research Reviews, 7(1), 1–7.
Meeusen, R., Duclos, M., Foster, C., Fry, A., Gleeson, M., Nieman, D., ... Urhausen, A. (2013). Prevention, diagnosis, and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 45(1), 186–205.
Minor, R. K., Smith, D. L., Sossong, A. M., Kaushik, S., Poosala, S., Spangler, E. L., ... Mattison, J. A. (2010). Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats. Toxicology and Applied Pharmacology, 243(3), 332–339.
Morton, J. P., MacLaren, D. P. M., Cable, N. T., Campbell, I. T., Evans, L., Bongers, T., ... Drust, B. (2007). Elevated core and muscle temperature to levels comparable to exercise do not increase heat shock protein content of skeletal muscle of physically active men. Acta Physiologica, 190(4), 319–327.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74(5), 1124–1136.
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., ... Ahn, K. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. Journal of Biological Chemistry, 285(11), 8340–8351.
Radak, Z., Chung, H. Y., Koltai, E., Taylor, A. W., & Goto, S. (2008). Exercise, oxidative stress and hormesis. Ageing Research Reviews, 7(1), 34–42.
Rattan, S. I. S. (2008). Hormesis in aging. Ageing Research Reviews, 7(1), 63–78.
Ristow, M., & Zarse, K. (2010). How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Experimental Gerontology, 45(6), 410–418.
Ritossa, F. (1962). A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia, 18(12), 571–573.
Schnohr, P., O’Keefe, J. H., Marott, J. L., Lange, P., & Jensen, G. B. (2015). Dose of jogging and long-term mortality: The Copenhagen City Heart Study. Journal of the American College of Cardiology, 65(5), 411–419.
Schulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007). Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metabolism, 6(4), 280–293.
Son, T. G., Camandola, S., & Mattson, M. P. (2008). Hormetic dietary phytochemicals. NeuroMolecular Medicine, 10(4), 236–246.
Southam, C. M., & Ehrlich, J. (1943). Effects of extract of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathology, 33(6), 517–524.
Tapia, P. C. (2006). Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: “Mitohormesis” for health and vitality. Medical Hypotheses, 66(4), 832–843.
Tissières, A., Mitchell, H. K., & Tracy, U. M. (1974). Protein synthesis in salivary glands of Drosophila melanogaster: Relation to chromosome puffs. Journal of Molecular Biology, 84(3), 389–398.
About the author: Seanna Marceaux, MS RDN, is ResilienZ Health’s Chief Science Officer and the dietitian who vetted the ResilienZ-12™ formulation. A Texas-licensed registered dietitian nutritionist with nearly 20 years in public health and aging, she holds a master’s degree in Human Nutrition from Texas State University, where she teaches graduate nutrition courses, and she has published peer-reviewed research on nutrition and aging.
More about Seanna’s background, research, and role at ResilienZ Health



